FINHUB Insights

TECH · Q3 FY26 · Jan 1 – Mar 31, 2026

Bio-Techne Q3 FY26: where the revenue came from and where it went

Bio-Techne Q3 FY26: revenue $0.31B (−2% year over year). Net profit $0.05B. Largest cohort Consumables $0.26B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jan 1 – Mar 31, 2026
Reported
May 6, 2026 10-Q
Sankey diagram of Bio-Techne's income statement for Q3 FY26: revenue of $0.31 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$0.31B −2% year over year
Gross profit$0.21B 67% margin
Operating profit$0.08B 24% margin
Net profit$0.05B 16% margin

The numbers

All figures in billions of U.S. dollars, for Q3 FY26 (period ends Mar 31, 2026).
ItemValueShare of revenueYear over year
Revenue 0.31 100% −2%
Consumables 0.26 83% +0%
Instruments 0.03 9% +6%
Service 0.02 7% −21%
Royalty 0.01 2% −1%
Cost of revenue−0.1033%
Gross profit0.2167% margin−1pp
SG&A−0.1135%−13pp
Other−0.028%+0pp
Operating profit0.0824% margin+12pp
Tax−0.02
Interest & other costs−<0.01
Net profit0.0516%+9pp
Filing on EDGAR More quarters of TECH

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.